News Headlines
Home » Gen. News » Health » FDA cautions against Glutathione pill

FDA cautions against Glutathione pill

The Food and Drugs Authority (FDA) is cautioning pregnant and lactating mothers to desist from taking Glutathione, a pill which is believed to lighten the skin of their babies.

The FDA says any person who takes such products does so at her own risk because the Authority cannot guarantee its safety, quality and efficacy.

The Chief Executive officer of the Authority, Delese Mimi Darko, at a news conference said the drug dosage causes side effects including hair loss, exacerbated Asthma, Toxic epidermal necrosis and renal failure.

GBCONLINE

Leave a Reply

Your email address will not be published.